1.Hamasaki, K, Nakata, K, Tsutsumi, T, et al. Changes in the prevalence of hepatitis B and hepatitis C infection in patients with hepatocellular carcinoma in the Nagasaki prefecture, Japan. J Med Virol 1993; 40: 146–9.
2.Takano, S, Yokosuka, O, Imazeki, F, Tagawa, M, Omata, M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients. Hepatology 1995; 21: 650–4.
3.Robinson, WS. Hepatitis B virus and hepatitis delta virus. In: Mandell, GL, Douglas, RG, Bennett, TE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1990: 1204–31.
4.Malik, IA, Luqman, M, Ahmad, A, et al. A clinicopathological study of viral hepatitis. Pakistan J Med Res 1987; 26: 4–11.
5.Malik, IA, Legters, LJ, Luqman, M, et al. The serological markers of hepatitis A and B in healthy population in northern Pakistan. J Pakistan M Assoc 1988; 38: 69–72.
6.Quraishi, MS, Zuberi, SJ, Ahmad, M. HBs-antigenaemia: Incidence in apparently healthy males. J Pakistan Med Assoc 1978; 28: 57.
7.Malik, IA, Tariq, WUZ. Viral hepatitis in Pakistan. Pakistan J Pathol 1993; 4: 1–5.
8.Cristiano, K, Di Bisceglie, AM, Hoofnagle, JH, Feinstone, SM. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology 1991; 14: 51–5.
9.Kwok, S, Higashi, R. Avoiding false positives with PCR. Nature 1989; 339: 237–8.
10.McOmish, F, Yap, LP, Dow, BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884–92.
11.Majid, A, Holmes, R, Desselberger, U, Simmonds, P, McKee, TA. Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J Med Virol 1995; 46: 48–51.
12.Simmonds, P, Rose, KA, Graham, S, et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1, 2 and 3. J Clin Microbiol 1993; 31: 1493–503.
13.Simmonds, P, Alberti, A, Alter, HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19 (suppl): 1321–4.
14.Paterlini, P, Gerken, G, Nakajima, E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80–5.
15.Linnen, J, Wages, J Jr, Zhang-Keck, Z-Y., et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmission agent. Science 1996; 271: 505–8.
16.Liaw, Y-F, Tsai, S-L, Chang, J-J, et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994; 106: 1048–53.
17.Sato, S, Fujiyama, S, Tanaka, M, et al. Co-infection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159–66.
18.Pontisso, P, Ruvoletto, MG, Fattovich, G, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529–33.
19.Mimms, LT, Mosley, JW, Hollinger, FB, et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993; 307: 1095–7.
20.Hanley, JP, Dolan, G, Day, S, Skidmore, SJ, Irving, WI. Interaction of hepatitis B and hepatitis C infection in haemophilia. Br J Haematol 1993; 85: 611–2.
21.Bukh, J, Miller, RH, Kew, MC, Purcell, RH. Hepatitis C virus RNA in southern African Blacks with hepatocellular carcinoma. Proc NatI Acad Sci 1993: 90; 1848–51.
22.Tsukuma, H, Hiyama, T, Tanaka, S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Eng J Med 1993; 328: 1797–801.
23.Okuno, H, Xie, Z-C, Lu, B-Y, et al. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, Southern China. Cancer 1994; 73: 58–62.
24.Kew, MC. Hepatitis C virus and hepatocellular carcinoma. FEMS Microbiol Rev 1994; 14: 211–20.
25.Blum, HE. Does hepatitis C virus cause hepatocellular carcinoma? Hepatology 1994; 19: 251–8.
26.Cuthbert, GJA. Hepatitis C: progress and problems. Clin Microbiol Rev 1994; 7: 505–32.
27.Simmonds, P. Variability of hepatitis C virus. Hepatology 1995; 21: 570–83.
28.Lau, JYN, Mizokami, M, Kolberg, JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 281–9.
29.Mahaney, K, Tedeschi, V, Maertens, G, et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology 1994; 20: 1405–11.
30.Dusheiko, G, Schmilovitz-Weiss, H, Brown, D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13–7.
31.Valliammai, T, Thyagarajan, SP, Zuckerman, AJ, Harrison, TJ. Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol 1995; 76: 711–6.
32.Lam, JPH, McOmish, F, Burns, SM, Yap, PL, Mok, JYQ, Simmonds, P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993; 167: 572–6.
33.Narendranathan, M, Philip, M. Reusable needles – a major risk factor for acute virus B infection. Tropical Doctor 1993; 23: 64–6.